Akira Oku

7.0k total citations
221 papers, 4.7k citations indexed

About

Akira Oku is a scholar working on Organic Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, Akira Oku has authored 221 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Organic Chemistry, 30 papers in Molecular Biology and 22 papers in Spectroscopy. Recurrent topics in Akira Oku's work include Cyclopropane Reaction Mechanisms (53 papers), Asymmetric Synthesis and Catalysis (46 papers) and Synthetic Organic Chemistry Methods (43 papers). Akira Oku is often cited by papers focused on Cyclopropane Reaction Mechanisms (53 papers), Asymmetric Synthesis and Catalysis (46 papers) and Synthetic Organic Chemistry Methods (43 papers). Akira Oku collaborates with scholars based in Japan, United States and United Kingdom. Akira Oku's co-authors include Toshiro Harada, Takeshi Katsuhira, Kiichiro Ueta, Etsu Yamada, Akira Saito, Mamoru Matsumoto, Masao Nawano, Yoshimichi Sai, Jun‐ichi Nezu and Ikumi Tamai and has published in prestigious journals such as Journal of the American Chemical Society, Diabetes and Chemical Communications.

In The Last Decade

Akira Oku

215 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akira Oku Japan 34 2.5k 979 717 484 400 221 4.7k
Xian‐Man Zhang United States 31 1.3k 0.5× 1.4k 1.4× 577 0.8× 588 1.2× 167 0.4× 66 3.7k
Roberta Seraglia Italy 37 1.1k 0.4× 1.3k 1.3× 562 0.8× 152 0.3× 402 1.0× 240 5.1k
Joseph E. Saavedra United States 42 969 0.4× 2.2k 2.2× 157 0.2× 263 0.5× 360 0.9× 168 6.8k
Kazunori Yanagi Japan 33 1.8k 0.7× 1.7k 1.8× 171 0.2× 165 0.3× 183 0.5× 82 4.4k
Vincent W. Bowry Australia 25 2.6k 1.0× 1.5k 1.5× 168 0.2× 243 0.5× 71 0.2× 35 4.9k
Yutaka Yoshikawa Japan 34 737 0.3× 976 1.0× 248 0.3× 189 0.4× 1.0k 2.5× 150 4.3k
Susana B. Etcheverry Argentina 37 867 0.3× 1.0k 1.1× 174 0.2× 141 0.3× 1.1k 2.8× 125 4.1k
Igor B. Afanasʹev Russia 26 954 0.4× 1.0k 1.1× 202 0.3× 95 0.2× 170 0.4× 67 3.7k
Koji Nakano Japan 37 2.8k 1.1× 401 0.4× 172 0.2× 131 0.3× 57 0.1× 112 5.2k
Thomas J. Curphey United States 26 840 0.3× 955 1.0× 235 0.3× 168 0.3× 334 0.8× 73 2.5k

Countries citing papers authored by Akira Oku

Since Specialization
Citations

This map shows the geographic impact of Akira Oku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Oku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Oku more than expected).

Fields of papers citing papers by Akira Oku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Oku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Oku. The network helps show where Akira Oku may publish in the future.

Co-authorship network of co-authors of Akira Oku

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Oku. A scholar is included among the top collaborators of Akira Oku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Oku. Akira Oku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asano, Hiroshi, Kanako C. Hatanaka, Ryosuke Matsuoka, et al.. (2019). L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy. Annals of Surgical Oncology. 27(7). 2159–2168. 20 indexed citations
2.
Yamada, Etsu, et al.. (2002). Monomer Recycling of Waste Poly (Ethylene Terephthalate) and its Life Cycle Assessment. Journal of the Japan Society of Waste Management Experts. 13(4). 201–208. 1 indexed citations
3.
Yasuda, Koichiro, Tetsuya Adachi, Yoshimasa Okamoto, et al.. (2002). Beneficial Effect Of T‐1095, A Selective Inhibitor Of Renal Na+–Glucose Cotransporters, On Metabolic Index And Insulin Secretion In Spontaneously Diabetic Gk Rats. Clinical and Experimental Pharmacology and Physiology. 29(5-6). 386–390. 25 indexed citations
4.
Harada, Toshiro & Akira Oku. (2001). Nucleophilic Reactivity of Alkynylmetals at the .BETA.-Position: Application to the Construction of Carbon Frameworks.. Journal of Synthetic Organic Chemistry Japan. 59(2). 101–108. 2 indexed citations
5.
Adachi, Tetsuya, Koichiro Yasuda, Yoshimasa Okamoto, et al.. (2000). T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats. Metabolism. 49(8). 990–995. 76 indexed citations
6.
Oku, Akira, Kiichiro Ueta, Masao Nawano, et al.. (2000). Antidiabetic effect of T-1095, an inhibitor of Na+-glucose cotransporter, in neonatally streptozotocin-treated rats. European Journal of Pharmacology. 391(1-2). 183–192. 49 indexed citations
7.
Oku, Akira, Kiichiro Ueta, Kenji Arakawa, et al.. (2000). Antihyperglycemic Effect of T-1095 via Inhibition of Renal Na+-Glucose Cotransporters in Streptozotocin-Induced Diabetic Rats.. Biological and Pharmaceutical Bulletin. 23(12). 1434–1437. 23 indexed citations
8.
Oku, Akira, Kiichiro Ueta, Kenji Arakawa, et al.. (2000). Correction of Hyperglycemia and Insulin Sensitivity by T-1095, an Inhibitor of Renal Na+-Glucose Cotransporters, in Streptozotocin-Induced Diabetic Rats. The Japanese Journal of Pharmacology. 84(3). 351–354. 22 indexed citations
10.
Tamai, Ikumi, Jun‐ichi Nezu, Kazuki Sakamoto, et al.. (1999). Novel Membrane Transporter OCTN1 Mediates Multispecific, Bidirectional, and pH-Dependent Transport of Organic Cations. Journal of Pharmacology and Experimental Therapeutics. 289(2). 768–773. 268 indexed citations
11.
Nawano, Masao, Kiichiro Ueta, Akira Oku, et al.. (1999). Hyperglycemia Impairs the Insulin Signaling Step between PI 3-Kinase and Akt/PKB Activations in ZDF Rat Liver. Biochemical and Biophysical Research Communications. 266(1). 252–256. 34 indexed citations
12.
Ohashi, Rikiya, Ikumi Tamai, Jun‐ichi Nezu, et al.. (1999). Na+-Dependent Carnitine Transport by Organic Cation Transporter (OCTN2): Its Pharmacological and Toxicological Relevance. Journal of Pharmacology and Experimental Therapeutics. 291(2). 778–784. 213 indexed citations
13.
Tsujihara, Kenji, Mitsuya Hongu, Kunio SAITO, et al.. (1996). Na+-Glucose Cotransporter Inhibitors as Antidiabetics. I. Synthesis and Pharmacological Properties of 4'-Dehydroxyphlorizin Derivatives Based on a New Concept.. Chemical and Pharmaceutical Bulletin. 44(6). 1174–1180. 70 indexed citations
14.
Oku, Akira. (1995). Highly Selective Synthetic Reactions for Constructing σ Molecular Frameworks Based on Carbenoid Chemistry. Journal of Synthetic Organic Chemistry Japan. 53(1). 2–12. 2 indexed citations
17.
Oku, Akira, et al.. (1983). Diels-Alder reaction of 6,6-dimethylfulvene with 2-acetoxyacrylonitrile. Preparation of 5-(2-hydroxyethyl)-2-cyclopenten-1-one. The Journal of Organic Chemistry. 48(23). 4374–4377. 3 indexed citations
18.
Oku, Akira, et al.. (1980). . NIPPON KAGAKU KAISHI. 1903–1906. 2 indexed citations
19.
Oku, Akira, et al.. (1978). . NIPPON KAGAKU KAISHI. 1577–1582. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026